The Gene Therapy Area of Major Interest (DIM Gene Therapy) launches the first edition of Gene Therapy for Rare Monogenic Diseases, an international symposium dedicated to recent knowledge and progress in the field to ensure faster and more efficacious development of therapies for diseases with high unmet medical needs. With 200 intended key actors, this two-day event is the unique opportunity to discover the latest gene therapy trends and to see emerge high-potential collaborations.
What does GTRD include ?
Keynotes with international high-level speakers from the Europe and the US, mainly focused on clinical gene therapy
Posters on the latest gene therapy trends and technologies
Presentations of research activities and major achievements from the Gene Therapy Area of Major Interest initiative research teams in the larger context of the recent progress in the field
Over 20 international experts from academia, industry and biotechs will address issues to discover the latest trends and approaches in the field of gene therapy, by sharing their expertise and knowledge.
Stanford Medicine, Department of Pediatrics
Katharine Dormandy Heamophilia Centre and Thrombosis Unit, Royal Free Hospital
Ophthalmological Foundation A. de Rothschild - Bichat Hospital
The Research Institute at Nationwide Children's
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Henri-Mondor University Hospital
National Institute of Blood Transfusion